Skip to main content
. 2015 Feb 6;10(2):e0116978. doi: 10.1371/journal.pone.0116978

Fig 4. Antiviral prophylactic rates in patients with positive of hepatitis B surface antigen (n = 134) undergoing chemotherapy in different cancer types.

Fig 4

The rates of antiviral prophylaxis in doctors treating lung, breast and colorectal cancers were significantly lower in doctors treating hematological cancers (all p < 0.05).